Consensus for FY23 revenue is $608.22M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TXG:
- 10x Genomics Reports Third Quarter 2023 Financial Results
- 10x Genomics: UPC declines to issue second injunction against NanoString
- 10x Genomics price target lowered to $47 from $66 at Barclays
- Bold NanoString investors ‘hard to find’ after injunction, says Stifel
- 10x Genomics EU win may not have clear readthrough to U.S., says Canaccord